Patents by Inventor Jeffrey Matthew Nivala

Jeffrey Matthew Nivala has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230212563
    Abstract: This invention provides methods of altering a cell including providing the cell with a nucleic acid sequence encoding a Cas1 protein and/or a Cas2 protein of a CRISPR adaptation system, providing the cell with a CRISPR array nucleic acid sequence including a leader sequence and at least one repeat sequence, wherein the cell expresses the Cas1 protein and/or the Cas2 protein and wherein the CRISPR array nucleic acid sequence is within genomic DNA of the cell or on a plasmid. Also provided are methods and systems for nucleic acid storage and in vivo molecular recordings of events into a cell.
    Type: Application
    Filed: April 11, 2022
    Publication date: July 6, 2023
    Inventors: George M. Church, Seth Lawler Shipman, Jeffrey D. Macklis, Jeffrey Matthew Nivala
  • Publication number: 20220277814
    Abstract: The disclosure provides compositions, systems, and related method for using nanopore-based detection of nucleic acid displacement circuits. In some embodiments, output strands contain orthogonal barcode sequences that are captured by nanopore systems to produce a unique and recognizable current signal. Machine learning models can be used to differentiate a plurality of current signals and, therefore, monitor detection and quantification of multiple nucleic acid displacement circuits in a single pot reaction.
    Type: Application
    Filed: July 24, 2020
    Publication date: September 1, 2022
    Applicant: University of Washington
    Inventor: Jeffrey Matthew Nivala
  • Patent number: 11339365
    Abstract: Described herein is a device and method for translocating a protein through a nanopore and monitoring electronic changes caused by different amino acids in the protein. The device comprises a nanopore in a membrane, an amplifier for providing a voltage between the cis side and trans side of the membrane, and an NTP driven unfoldase which processed the protein to be translocated. The exemplified unfoldase is the ClpX unfoldase from E. coli.
    Type: Grant
    Filed: February 15, 2013
    Date of Patent: May 24, 2022
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Jeffrey Matthew Nivala, Douglas Benjamin Marks, Mark Albert Akeson
  • Patent number: 11326161
    Abstract: This invention provides methods of altering a cell including providing the cell with a nucleic acid sequence encoding a Cas1 protein and/or a Cas2 protein of a CRISPR adaptation system, providing the cell with a CRISPR array nucleic acid sequence including a leader sequence and at least one repeat sequence, wherein the cell expresses the Cas1 protein and/or the Cas2 protein and wherein the CRISPR array nucleic acid sequence is within genomic DNA of the cell or on a plasmid. Also provided are methods and systems for nucleic acid storage and in vivo molecular recordings of events into a cell.
    Type: Grant
    Filed: February 16, 2017
    Date of Patent: May 10, 2022
    Assignee: President and Fellows of Harvard College
    Inventors: George M. Church, Seth Lawler Shipman, Jeffrey D. Macklis, Jeffrey Matthew Nivala
  • Publication number: 20210340192
    Abstract: The disclosure provides fusion reporter protein constructs and related compositions, systems, and methods for nanopore-based detection biological activity. In one aspect, the disclosure provides a fusion reporter protein comprising, in order: a blocking domain with a stably folded tertiary structure; a flexible analyte domain; and a flexible tail domain, wherein the flexible tail domain has a net negative charge. The disclosure also provides nucleic acid constructs encoding the disclosed fusion reporter protein, and vectors and cells comprising the nucleic acids. Also provided are nanopore-based systems and methods for using the disclosed fusion reporter protein constructs to detect and characterize biological activity.
    Type: Application
    Filed: October 4, 2019
    Publication date: November 4, 2021
    Applicant: UNIVERSITY OF WASHINGTON
    Inventor: Jeffrey Matthew NIVALA
  • Publication number: 20210230588
    Abstract: This invention provides methods of altering a cell including providing the cell with a nucleic acid sequence encoding a Cas1 protein and/or a Cas2 protein of a CRISPR adaptation system, providing the cell with a CRISPR array nucleic acid sequence including a leader sequence and at least one repeat sequence, wherein the cell expresses the Cas1 protein and/or the Cas2 protein and wherein the CRISPR array nucleic acid sequence is within genomic DNA of the cell or on a plasmid. Also provided are methods and systems for nucleic acid storage and in vivo molecular recordings of events into a cell.
    Type: Application
    Filed: February 16, 2017
    Publication date: July 29, 2021
    Inventors: George M. Church, Seth Lawler Shipman, Jeffrey D. Manklis, Jeffrey Matthew Nivala
  • Patent number: 10883140
    Abstract: This invention provides methods and systems of DNA synthesis including providing an encoding unit comprising an enzyme, a single-stranded DNA (ssDNA) and a nanopore, providing a lipid bilayer having on opposite sides a cis and a trans reservoir each having a different buffer composition, wherein the nanopore is within the lipid bilayer and the enzyme and the ssDNA are in the cis reservoir, providing an electrode over the lipid bilayer wherein the electrode can modulate voltage across the lipid bilayer, wherein the enzyme catalyzes DNA synthesis in response to the voltage.
    Type: Grant
    Filed: April 19, 2017
    Date of Patent: January 5, 2021
    Assignee: President and Fellows of Harvard College
    Inventors: George M. Church, Mirkó Palla, Peter Benjamin Stranges, Jeffrey Matthew Nivala
  • Publication number: 20200190534
    Abstract: This invention provides methods of altering a cell including providing the cell with a nucleic acid sequence encoding a Cas1 protein and/or a Cas2 protein of a CRISPR adaptation system, providing the cell with a consensus CRISPR array nucleic acid sequence including a leader sequence and at least one consensus repeat sequence, and wherein the cell expresses the Cas1 protein and/or the Cas2 protein.
    Type: Application
    Filed: April 27, 2018
    Publication date: June 18, 2020
    Inventors: Jeffrey Matthew Nivala, Seth Lawler Shipman, George M. Church
  • Publication number: 20200115706
    Abstract: This invention provides methods of altering a cell including providing the cell with a nucleic acid sequence encoding a Cas1 protein and/or a Cas2 protein of a CRISPR adaptation system, providing the cell with a CRISPR array nucleic acid sequence including a leader sequence and at least one repeat sequence, and providing the cell with one or more retron systems, wherein the cell expresses the Cas1 protein and/or the Cas2 protein.
    Type: Application
    Filed: April 12, 2018
    Publication date: April 16, 2020
    Inventors: Seth Lawler Shipman, Jeffrey Matthew Nivala, George M. Church, Max Schubert
  • Publication number: 20190136309
    Abstract: This invention provides methods and systems of DNA synthesis including providing an encoding unit comprising an enzyme, a single-stranded DNA (ssDNA) and a nanopore, providing a lipid bilayer having on opposite sides a cis and a trans reservoir each having a different buffer composition, wherein the nanopore is within the lipid bilayer and the enzyme and the ssDNA are in the cis reservoir, providing an electrode over the lipid bilayer wherein the electrode can modulate voltage across the lipid bilayer, wherein the enzyme catalyzes DNA synthesis in response to the voltage.
    Type: Application
    Filed: April 19, 2017
    Publication date: May 9, 2019
    Applicant: President and Fellows of Harvard College
    Inventors: George M. Church, Mirkó Palla, Peter Benjamin Stranges, Jeffrey Matthew Nivala